Offer - Urjas Oil for just ₹ 1
Reditux RA Infusion, a prescription drug, is manufactured in various forms such as Infusion. It is primarily used for the treatment of Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia. Other than this, Reditux RA Infusion has some other therapeutic uses, which have been discussed ahead.
The optimal dosage of Reditux RA Infusion is largely dependent on the individual's body weight, medical history, gender and age. Individual symptoms and route of administration also determines the right dosage. This information has been provided in detail in the dosage section.
The most common side effects of Reditux RA Infusion are Weakness. Some other side effects of Reditux RA Infusion have been listed ahead. These side effects of Reditux RA Infusion are usually temporary and subside with the completion of treatment. Consult your doctor if these side effects become worse or stay for a longer duration.
It is also important to note that Reditux RA Infusion has a Moderate effect for pregnant women and Severe effect on lactating mothers. Further, the section on Reditux RA Infusion related warnings talks about Reditux RA Infusion's effects on the liver, heart and kidney.
Reditux RA Infusion can cause adverse effects in certain medical conditions. It is strongly recommended to avoid Reditux RA Infusion in conditions like Hyperkalemia. Some other conditions that can be affected by Reditux RA Infusion are listed in the contraindications section below.
Drug reaction of Reditux RA Infusion with other medicines has been reported. A complete list of these interactions is given below.
Along with the above-mentioned precautions, remember that taking Reditux RA Infusion is considered not safe while driving, and is not addictive.
Reditux RA Infusion is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Geriatric |
|
Is the use of Reditux RA Infusion safe for pregnant women?
Reditux RA can cause unwanted side effects in pregnant women. If you experience any side effects, stop taking Reditux RA right away. Take your doctor's advice before taking it again.
Is the use of Reditux RA Infusion safe during breastfeeding?
Reditux RA should not be taken without taking your doctor's advice, as it may have severe side effects on breastfeeding women.
What is the effect of Reditux RA Infusion on the Kidneys?
There may be some adverse effects on kidney after taking Reditux RA. If you observe any such side effects, stop taking this drug. Consume this medicine again only if your doctor advises you to do so.
What is the effect of Reditux RA Infusion on the Liver?
Reditux RA does not damage the liver.
What is the effect of Reditux RA Infusion on the Heart?
Reditux RA may cause harmful effects on the heart. if you feel it's having any such effect, then stop taking this drug, and restart only on your doctor's advice.
If you are suffering from any of the following diseases, you should not take Reditux RA Infusion unless your doctor advises you to do so -
Is this Reditux RA Infusion habit forming or addictive?
Forming a habit of Reditux RA Infusion has not been reported.
Is it safe to drive or operate heavy machinery when consuming?
No, you should not drive or operate heavy machinery after taking Reditux RA Infusion as you may feel sleepy.
Is it safe?
Yes, Reditux RA Infusion is safe but you must consult your doctor before taking it.
Is it able to treat mental disorders?
No, Reditux RA Infusion cannot treat any kind of mental disorder.
Interaction between Food and Reditux RA Infusion
Taking Reditux RA Infusion with food does not harm your health.
Interaction between Alcohol and Reditux RA Infusion
Information about the interaction of Reditux RA Infusion and alcohol is not currently available because this topic has not been researched yet.
This medicine data has been created by -
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Rituxan (rituximab)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1106-1109
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 872
